MYCOPHENOLATE MOFETIL

MYCOPHENOLATE MOFETIL was reported 75195 times

MYCOPHENOLATE MOFETIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SMOOTH MUSCLE CELL NEOPLASM 119 0.6761
1 TRANSPLANT DYSFUNCTION 772 0.6161
2 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 802 0.6141
3 RENAL GRAFT INFECTION 73 0.6083
4 TRICHODYSPLASIA SPINULOSA 145 0.5823
5 DELAYED GRAFT FUNCTION 251 0.5783
6 CYTOMEGALOVIRUS SYNDROME 67 0.5678
7 PHAEOHYPHOMYCOSIS 121 0.5525
8 CHRONIC ALLOGRAFT NEPHROPATHY 305 0.5417
9 HEART TRANSPLANT REJECTION 426 0.5253
10 TRANSPLANT REJECTION 2830 0.5118
11 EXTERNAL AUDITORY CANAL ATRESIA 72 0.5106
12 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 77 0.5066
13 PANCREAS TRANSPLANT REJECTION 74 0.4654
14 POLYOMAVIRUS VIRAEMIA 146 0.4650
15 COMPLICATIONS OF TRANSPLANTED HEART 74 0.4512
16 COMPLICATIONS OF TRANSPLANTED KIDNEY 738 0.4375
17 BK VIRUS INFECTION 821 0.4305
18 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1187 0.4235
19 HUMAN POLYOMAVIRUS INFECTION 136 0.4134
20 GRAFT DYSFUNCTION 114 0.3972
21 PULMONARY MUCORMYCOSIS 53 0.3897
22 KIDNEY TRANSPLANT REJECTION 1468 0.3874
23 MICROTIA 112 0.3862
24 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 70 0.3846
25 LUNG TRANSPLANT REJECTION 174 0.3799
26 PARVOVIRUS B19 INFECTION 123 0.3750
27 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 177 0.3726
28 COMPLICATIONS OF TRANSPLANTED LUNG 65 0.3652
29 CRYPTOSPORIDIOSIS INFECTION 102 0.3604
30 SLE ARTHRITIS 75 0.3589
31 ALTERNARIA INFECTION 68 0.3579
32 GRAFT LOSS 213 0.3568
33 CYSTITIS VIRAL 63 0.3559
34 RENAL TRANSPLANT FAILURE 217 0.3506
35 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 67 0.3472
36 LYMPHOCELE 200 0.3413
37 GRAFT VERSUS HOST DISEASE IN LUNG 110 0.3406
38 CYTOMEGALOVIRUS VIRAEMIA 791 0.3373
39 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 307 0.3344
40 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 426 0.3333
41 MICROSPORIDIA INFECTION 69 0.3286
42 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 154 0.3229
43 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 542 0.3201
44 LIVER TRANSPLANT REJECTION 437 0.3080
45 GRAFT VERSUS HOST DISEASE IN SKIN 422 0.2982
46 ADENOVIRUS INFECTION 528 0.2975
47 POST TRANSPLANT DISTAL LIMB SYNDROME 55 0.2910
48 RENAL TUBULAR ATROPHY 181 0.2905
49 GRAFT VERSUS HOST DISEASE IN LIVER 126 0.2877
50 CYTOMEGALOVIRUS INFECTION 3286 0.2870
51 CHRONIC GRAFT VERSUS HOST DISEASE 688 0.2862
52 CYTOMEGALOVIRUS INFECTION REACTIVATION 309 0.2807
53 CHOROIDITIS 68 0.2787
54 HUMAN HERPESVIRUS 8 INFECTION 88 0.2776
55 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 544 0.2727
56 TRANSPLANT FAILURE 478 0.2716
57 ELBOW DEFORMITY 74 0.2681
58 ACUTE GRAFT VERSUS HOST DISEASE 903 0.2661
59 ENCEPHALITIS CYTOMEGALOVIRUS 59 0.2658
60 EPSTEIN-BARR VIRAEMIA 151 0.2640
61 CYTOMEGALOVIRUS ENTERITIS 57 0.2500
62 VARICELLA ZOSTER VIRUS INFECTION 310 0.2474
63 VIRAL HAEMORRHAGIC CYSTITIS 88 0.2472
64 HEPATIC ARTERY THROMBOSIS 55 0.2455
65 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 78 0.2445
66 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 221 0.2434
67 CEREBRAL TOXOPLASMOSIS 135 0.2381
68 CYTOMEGALOVIRUS COLITIS 301 0.2357
69 APOPTOSIS 52 0.2332
70 LUPUS NEPHRITIS 203 0.2315
71 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 80 0.2273
72 WEST NILE VIRAL INFECTION 105 0.2263
73 SCEDOSPORIUM INFECTION 90 0.2261
74 HYPERCREATINAEMIA 51 0.2257
75 VIRAEMIA 178 0.2253
76 EPSTEIN-BARR VIRUS INFECTION 934 0.2207
77 DISSEMINATED CRYPTOCOCCOSIS 78 0.2185
78 HUMAN HERPESVIRUS 6 INFECTION 314 0.2178
79 PNEUMONIA CYTOMEGALOVIRAL 274 0.2157
80 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 243 0.2130
81 INFECTION REACTIVATION 131 0.2123
82 JC VIRUS INFECTION 206 0.2115
83 TOXOPLASMOSIS 166 0.2096
84 MUCORMYCOSIS 326 0.2087
85 COMPLICATIONS OF TRANSPLANTED LIVER 64 0.2085
86 NOCARDIOSIS 334 0.2084
87 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 213 0.2046
88 CYTOMEGALOVIRUS TEST POSITIVE 252 0.2024
89 CRYPTOCOCCOSIS 182 0.2020
90 STRONGYLOIDIASIS 220 0.2016
91 HEPATITIS E 194 0.1968
92 ALVEOLAR PROTEINOSIS 61 0.1930
93 PARVOVIRUS INFECTION 53 0.1906
94 KIDNEY FIBROSIS 230 0.1865
95 MYCOBACTERIUM ABSCESSUS INFECTION 67 0.1861
96 GRAFT VERSUS HOST DISEASE 1005 0.1839
97 RENAL TUBULAR INJURY 77 0.1799
98 PNEUMOCYSTIS JIROVECII INFECTION 101 0.1784
99 CENTRAL NERVOUS SYSTEM LYMPHOMA 139 0.1740
100 HISTOPLASMOSIS DISSEMINATED 144 0.1737
101 URETERIC STENOSIS 102 0.1735
102 CYSTITIS HAEMORRHAGIC 443 0.1592
103 OBLITERATIVE BRONCHIOLITIS 164 0.1591
104 ASPERGILLUS INFECTION 561 0.1583
105 OESOPHAGEAL ATRESIA 80 0.1556
106 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 53 0.1554
107 GRAFT COMPLICATION 69 0.1533
108 ACINETOBACTER INFECTION 114 0.1496
109 THROMBOTIC MICROANGIOPATHY 881 0.1494
110 COMPLICATIONS OF TRANSPLANT SURGERY 66 0.1486
111 ANGIOSARCOMA 50 0.1475
112 INFECTION IN AN IMMUNOCOMPROMISED HOST 69 0.1468
113 EPSTEIN-BARR VIRUS TEST POSITIVE 66 0.1460
114 MYCOPLASMA INFECTION 54 0.1456
115 MENINGITIS CRYPTOCOCCAL 150 0.1401
116 ENCEPHALITIS VIRAL 123 0.1395
117 KLEBSIELLA INFECTION 435 0.1359
118 STEROID DIABETES 81 0.1346
119 BLOOD IRON ABNORMAL 89 0.1338
120 BRAIN ABSCESS 215 0.1324
121 VISCERAL LEISHMANIASIS 53 0.1283
122 BRONCHOPULMONARY ASPERGILLOSIS 626 0.1282
123 GLOMERULOSCLEROSIS 62 0.1265
124 KAPOSI'S SARCOMA 63 0.1252
125 APLASIA PURE RED CELL 311 0.1239
126 CYTOMEGALOVIRUS ENTEROCOLITIS 54 0.1216
127 CEREBRAL ASPERGILLOSIS 50 0.1182
128 HYPOGAMMAGLOBULINAEMIA 378 0.1176
129 MYCOBACTERIAL INFECTION 145 0.1174
130 ENTEROCOCCAL INFECTION 373 0.1158
131 PSEUDOMONAL BACTERAEMIA 53 0.1145
132 GASTROENTERITIS NOROVIRUS 122 0.1134
133 PNEUMONIA CRYPTOCOCCAL 56 0.1129
134 PNEUMOCYSTIS JIROVECII PNEUMONIA 651 0.1120
135 IGA NEPHROPATHY 93 0.1118
136 CYTOMEGALOVIRUS CHORIORETINITIS 141 0.1112
137 ZYGOMYCOSIS 52 0.1106
138 STENOTROPHOMONAS INFECTION 91 0.1106
139 BLOOD PRESSURE DIASTOLIC ABNORMAL 134 0.1091
140 HAEMOLYTIC URAEMIC SYNDROME 214 0.1087
141 HISTOPLASMOSIS 142 0.1081
142 ENTEROCOCCAL SEPSIS 68 0.1081
143 URINARY TRACT INFECTION ENTEROCOCCAL 82 0.1072
144 LYMPHOPROLIFERATIVE DISORDER 205 0.1052
145 KLEBSIELLA SEPSIS 81 0.1051
146 GLOMERULONEPHRITIS 167 0.1021
147 ASPERGILLOSIS 133 0.1015
148 DRUG LEVEL FLUCTUATING 63 0.0956
149 GRANULOMATOSIS WITH POLYANGIITIS 63 0.0945
150 ENTEROCOCCAL BACTERAEMIA 61 0.0943
151 PYELONEPHRITIS ACUTE 130 0.0941
152 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 564 0.0929
153 PNEUMONIA KLEBSIELLA 108 0.0919
154 PSEUDOMONAS INFECTION 499 0.0916
155 DIFFUSE LARGE B-CELL LYMPHOMA 363 0.0915
156 SYSTEMIC MYCOSIS 64 0.0908
157 NEPHROPATHY TOXIC 632 0.0906
158 GINGIVAL HYPERTROPHY 77 0.0889
159 MICROANGIOPATHY 60 0.0888
160 PNEUMONIA INFLUENZAL 60 0.0885
161 BACTERIAL SEPSIS 203 0.0870
162 SYSTEMIC CANDIDA 124 0.0867
163 ANOGENITAL WARTS 55 0.0859
164 ACTINIC KERATOSIS 164 0.0855
165 ENTEROBACTER INFECTION 98 0.0854
166 VENOOCCLUSIVE DISEASE 148 0.0854
167 CANDIDA SEPSIS 58 0.0850
168 BILE DUCT STENOSIS 74 0.0844
169 FUNGAEMIA 85 0.0839
170 RENAL ARTERY STENOSIS 91 0.0824
171 TRANSITIONAL CELL CARCINOMA 65 0.0793
172 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 187 0.0786
173 PARAINFLUENZAE VIRUS INFECTION 71 0.0759
174 CUSHINGOID 164 0.0753
175 ACUTE MYELOID LEUKAEMIA RECURRENT 75 0.0732
176 URINARY TRACT INFECTION BACTERIAL 117 0.0729
177 NEPHROTIC SYNDROME 347 0.0722
178 DYSPLASIA 59 0.0715
179 RENAL TRANSPLANT 177 0.0713
180 VENOOCCLUSIVE LIVER DISEASE 225 0.0694
181 RENAL TUBULAR NECROSIS 489 0.0690
182 ESCHERICHIA INFECTION 365 0.0688
183 GLOMERULONEPHRITIS MEMBRANOUS 54 0.0684
184 PNEUMOMEDIASTINUM 72 0.0680
185 COCCIDIOIDOMYCOSIS 57 0.0679
186 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 405 0.0673
187 PAPILLOMA VIRAL INFECTION 73 0.0667
188 NEPHRECTOMY 64 0.0665
189 MYCOBACTERIUM AVIUM COMPLEX INFECTION 104 0.0663
190 ESCHERICHIA SEPSIS 139 0.0657
191 ESCHERICHIA BACTERAEMIA 88 0.0649
192 MULTIPLE ORGAN DYSFUNCTION SYNDROME 974 0.0649
193 PNEUMONIA FUNGAL 120 0.0643
194 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 147 0.0634
195 HERPES SIMPLEX 288 0.0628
196 RHINOVIRUS INFECTION 102 0.0618
197 PNEUMATOSIS INTESTINALIS 104 0.0600
198 DIFFUSE ALVEOLAR DAMAGE 52 0.0598
199 SQUAMOUS CELL CARCINOMA OF SKIN 230 0.0598
200 BRONCHIECTASIS 233 0.0592
201 LEUKAEMIA RECURRENT 77 0.0585
202 OPPORTUNISTIC INFECTION 81 0.0583
203 COVID-19 PNEUMONIA 217 0.0581
204 ESCHERICHIA URINARY TRACT INFECTION 180 0.0579
205 BLOOD PRESSURE SYSTOLIC ABNORMAL 64 0.0576
206 HISTIOCYTOSIS HAEMATOPHAGIC 173 0.0572
207 STAPHYLOCOCCAL BACTERAEMIA 157 0.0568
208 PROTEINURIA 684 0.0567
209 FUNGAL SKIN INFECTION 151 0.0557
210 PYELONEPHRITIS 332 0.0557
211 DERMATOMYOSITIS 84 0.0543
212 RENAL TUBULAR DISORDER 118 0.0511
213 BONE MARROW TOXICITY 62 0.0510
214 DISSEMINATED TUBERCULOSIS 92 0.0509
215 HEPATIC FIBROSIS 121 0.0509
216 ENCEPHALITIS 233 0.0509
217 BACTERAEMIA 380 0.0506
218 PSEUDOMONAL SEPSIS 61 0.0504
219 SCLERODERMA 138 0.0502
220 THERAPY PARTIAL RESPONDER 174 0.0501
221 OVARIAN CYST 401 0.0501
222 HEPATITIS B REACTIVATION 96 0.0499
223 VARICELLA 89 0.0494
224 SKIN INDURATION 76 0.0494
225 BONE EROSION 103 0.0494
226 RENAL TUBULAR ACIDOSIS 69 0.0480
227 BLOOD IMMUNOGLOBULIN G DECREASED 51 0.0477
228 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 82 0.0475
229 WOUND DEHISCENCE 124 0.0474
230 LARGE INTESTINAL ULCER 90 0.0471
231 FIBROSIS 107 0.0469
232 AUTOIMMUNE HAEMOLYTIC ANAEMIA 94 0.0468
233 NEPHROGENIC SYSTEMIC FIBROSIS 139 0.0465
234 ACUTE RESPIRATORY DISTRESS SYNDROME 576 0.0457
235 ABDOMINAL INFECTION 76 0.0457
236 PNEUMONIA VIRAL 92 0.0456
237 LYMPHOPENIA 414 0.0449
238 SOFT TISSUE INFECTION 55 0.0448
239 SERUM SICKNESS 93 0.0447
240 CHOLANGITIS SCLEROSING 51 0.0445
241 CHOLANGITIS 172 0.0442
242 PNEUMONIA BACTERIAL 215 0.0441
243 GRANULOMA 108 0.0440
244 HYDRONEPHROSIS 232 0.0436
245 SQUAMOUS CELL CARCINOMA 286 0.0422
246 PEMPHIGUS 197 0.0421
247 PATHOGEN RESISTANCE 233 0.0421
248 ORGANISING PNEUMONIA 124 0.0420
249 SEPTIC SHOCK 1199 0.0413
250 AGRANULOCYTOSIS 482 0.0413
251 LEUKOPENIA 1444 0.0411
252 B-CELL LYMPHOMA 108 0.0408
253 APLASIA 70 0.0407
254 OESOPHAGEAL CANDIDIASIS 108 0.0400
255 PNEUMONIA STAPHYLOCOCCAL 59 0.0400
256 ENDOCARDITIS 144 0.0400
257 PULMONARY ALVEOLAR HAEMORRHAGE 141 0.0397
258 VASCULAR PSEUDOANEURYSM 51 0.0392
259 INTENTIONAL PRODUCT USE ISSUE 1820 0.0391
260 PNEUMOCYSTIS JIROVECI PNEUMONIA 87 0.0389
261 NECROTISING FASCIITIS 93 0.0388
262 MYASTHENIA GRAVIS 127 0.0388
263 LIVER ABSCESS 84 0.0387
264 SKIN PAPILLOMA 110 0.0386
265 LUNG CONSOLIDATION 79 0.0383
266 SKIN HYPERTROPHY 75 0.0383
267 MYOPATHY 241 0.0382
268 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 112 0.0381
269 PRODUCT USE IN UNAPPROVED INDICATION 4543 0.0381
270 DRUG LEVEL INCREASED 431 0.0378
271 HEPATIC NECROSIS 118 0.0377
272 DISEASE RECURRENCE 615 0.0374
273 LUNG ADENOCARCINOMA 77 0.0370
274 LUNG ABSCESS 54 0.0370
275 BLOOD CREATININE INCREASED 1768 0.0365
276 PULMONARY TUBERCULOSIS 121 0.0365
277 LEUKOENCEPHALOPATHY 103 0.0364
278 STAPHYLOCOCCAL SEPSIS 140 0.0363
279 CANDIDA INFECTION 370 0.0362
280 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 130 0.0362
281 HAEMODYNAMIC INSTABILITY 174 0.0360
282 CLOSTRIDIUM DIFFICILE COLITIS 268 0.0358
283 LIVER TRANSPLANT 96 0.0352
284 NEPHRITIS 76 0.0350
285 UROSEPSIS 222 0.0348
286 HERPES VIRUS INFECTION 142 0.0345
287 AZOTAEMIA 98 0.0344
288 OLIGURIA 162 0.0343
289 RESPIRATORY SYNCYTIAL VIRUS INFECTION 120 0.0343
290 HEPATOSPLENOMEGALY 67 0.0337
291 HAEMOLYTIC ANAEMIA 228 0.0333
292 HEPATITIS C 354 0.0330
293 SCIATICA 316 0.0329
294 ENTERITIS 130 0.0328
295 STEM CELL TRANSPLANT 58 0.0327
296 ENDOPHTHALMITIS 131 0.0325
297 ENTEROCOLITIS 108 0.0321
298 BACTERIAL INFECTION 379 0.0316
299 HAEMODIALYSIS 250 0.0315
300 GUILLAIN-BARRE SYNDROME 100 0.0314
301 DYSLIPIDAEMIA 108 0.0312
302 PROSTATITIS 70 0.0312
303 NEUROTOXICITY 329 0.0312
304 WOUND INFECTION 193 0.0309
305 ANURIA 211 0.0306
306 PANCYTOPENIA 1178 0.0306
307 RENAL IMPAIRMENT 1684 0.0304
308 C-REACTIVE PROTEIN ABNORMAL 87 0.0302
309 MULTI-ORGAN FAILURE 522 0.0301
310 IMMUNOSUPPRESSION 152 0.0301
311 HEPATITIS CHOLESTATIC 128 0.0298
312 DRUG RESISTANCE 483 0.0295
313 HYPERURICAEMIA 86 0.0295
314 THROMBOTIC THROMBOCYTOPENIC PURPURA 85 0.0290
315 TUBULOINTERSTITIAL NEPHRITIS 376 0.0290
316 SKIN NECROSIS 116 0.0290
317 COVID-19 968 0.0289
318 LUNG INFILTRATION 218 0.0288
319 AUTOIMMUNE HEPATITIS 131 0.0286
320 NECROSIS 121 0.0281
321 CYTOPENIA 144 0.0281
322 SYSTEMIC LUPUS ERYTHEMATOSUS 515 0.0280
323 RESPIRATORY FAILURE 1520 0.0280
324 APLASTIC ANAEMIA 101 0.0279
325 HYPERBILIRUBINAEMIA 195 0.0274
326 BLOOD CULTURE POSITIVE 72 0.0271
327 BASAL CELL CARCINOMA 294 0.0270
328 CANDIDIASIS 108 0.0269
329 HEPATITIS B 126 0.0268
330 APHTHOUS ULCER 101 0.0267
331 DRUG LEVEL DECREASED 155 0.0266
332 PNEUMONIA ASPIRATION 462 0.0265
333 PORTAL HYPERTENSION 58 0.0265
334 SEPSIS 2092 0.0262
335 RENAL CELL CARCINOMA 96 0.0257
336 ARTHRITIS BACTERIAL 73 0.0253
337 PULMONARY FUNCTION TEST DECREASED 85 0.0253
338 BRAIN HERNIATION 56 0.0253
339 NORMOCHROMIC NORMOCYTIC ANAEMIA 58 0.0253
340 RALES 105 0.0252
341 VASCULITIS 197 0.0251
342 GROWTH RETARDATION 55 0.0251
343 VIRAL LOAD INCREASED 58 0.0250
344 URINE OUTPUT DECREASED 171 0.0249
345 END STAGE RENAL DISEASE 380 0.0249
346 LUNG INFECTION 390 0.0249
347 PAPULE 98 0.0248
348 ODYNOPHAGIA 99 0.0247
349 OESOPHAGEAL ULCER 75 0.0247
350 SHOCK HAEMORRHAGIC 136 0.0246
351 DISSEMINATED INTRAVASCULAR COAGULATION 273 0.0245
352 GASTROINTESTINAL TOXICITY 64 0.0245
353 BONE MARROW FAILURE 438 0.0244
354 MENINGITIS ASEPTIC 73 0.0243
355 MENINGITIS 115 0.0241
356 SUBCUTANEOUS ABSCESS 86 0.0241
357 CREPITATIONS 57 0.0239
358 HYPOALBUMINAEMIA 122 0.0239
359 CHOLESTASIS 312 0.0237
360 ASCITES 503 0.0237
361 HEPATOCELLULAR CARCINOMA 130 0.0236
362 STAPHYLOCOCCAL INFECTION 596 0.0235
363 MYOCARDITIS 138 0.0232
364 PROTEIN URINE PRESENT 80 0.0232
365 CARDIAC TAMPONADE 79 0.0230
366 RED BLOOD CELL SEDIMENTATION RATE INCREASED 172 0.0230
367 HYPERAMMONAEMIA 78 0.0230
368 OTITIS MEDIA 58 0.0229
369 GASTROENTERITIS 242 0.0229
370 POSTOPERATIVE WOUND INFECTION 101 0.0228
371 HYPERTRIGLYCERIDAEMIA 91 0.0227
372 DUODENITIS 52 0.0227
373 LARGE INTESTINE PERFORATION 115 0.0226
374 ACIDOSIS 130 0.0226
375 ENCEPHALOPATHY 378 0.0225
376 UVEITIS 166 0.0225
377 BLOOD CREATINE INCREASED 69 0.0224
378 DRUG LEVEL ABOVE THERAPEUTIC 56 0.0223
379 CHRONIC MYELOID LEUKAEMIA 74 0.0222
380 MUCOSAL INFLAMMATION 402 0.0221
381 SKIN MASS 92 0.0218
382 SPLENOMEGALY 186 0.0218
383 CACHEXIA 81 0.0216
384 ACUTE RESPIRATORY FAILURE 264 0.0216
385 FAILURE TO THRIVE 89 0.0216
386 LEFT VENTRICULAR HYPERTROPHY 70 0.0215
387 INTERSTITIAL LUNG DISEASE 690 0.0215
388 TOXIC ENCEPHALOPATHY 65 0.0213
389 NEUROLOGICAL SYMPTOM 84 0.0212
390 POLYARTHRITIS 69 0.0212
391 TUBERCULOSIS 188 0.0211
392 GLUCOSE TOLERANCE IMPAIRED 83 0.0210
393 HYPERCALCAEMIA 182 0.0209
394 CARDIAC FAILURE ACUTE 88 0.0209
395 PULMONARY HAEMORRHAGE 128 0.0208
396 DRUG LEVEL BELOW THERAPEUTIC 64 0.0206
397 TREATMENT FAILURE 1046 0.0206
398 HAEMATOTOXICITY 109 0.0204
399 MYOSITIS 118 0.0203
400 BLOOD UREA INCREASED 277 0.0202
401 COLITIS 463 0.0200
402 DEMYELINATION 61 0.0200
403 HAEMOLYSIS 115 0.0199
404 FUNGAL INFECTION 454 0.0197
405 SKIN LESION 359 0.0196
406 ACUTE KIDNEY INJURY 1912 0.0196
407 HYPERKALAEMIA 490 0.0195
408 SKIN TOXICITY 61 0.0195
409 NEPHROPATHY 140 0.0195
410 MULTIPLE ALLERGIES 94 0.0194
411 PERITONITIS 312 0.0194
412 RESPIRATORY DISTRESS 400 0.0193
413 HYPOXIA 462 0.0192
414 MOUTH ULCERATION 271 0.0192
415 HERPES ZOSTER 770 0.0191
416 NEUTROPENIA 1532 0.0190
417 HYDROCEPHALUS 76 0.0189
418 CORONAVIRUS INFECTION 62 0.0189
419 STATUS EPILEPTICUS 152 0.0188
420 HYPOVOLAEMIA 82 0.0187
421 STREPTOCOCCAL INFECTION 67 0.0185
422 ACUTE HEPATIC FAILURE 167 0.0185
423 SKIN INFECTION 133 0.0185
424 BLOOD ALBUMIN DECREASED 109 0.0183
425 THERAPY NON-RESPONDER 400 0.0181
426 BLOOD BILIRUBIN INCREASED 377 0.0181
427 ACUTE MYELOID LEUKAEMIA 193 0.0180
428 HEPATOTOXICITY 259 0.0180
429 TRANSAMINASES INCREASED 293 0.0180
430 BRAIN OEDEMA 165 0.0179
431 DIARRHOEA HAEMORRHAGIC 119 0.0179
432 INTRACRANIAL PRESSURE INCREASED 71 0.0179
433 BLOOD LACTATE DEHYDROGENASE INCREASED 226 0.0178
434 RENAL FAILURE CHRONIC 136 0.0177
435 GLOMERULAR FILTRATION RATE DECREASED 122 0.0176
436 PULMONARY MASS 171 0.0175
437 ABDOMINAL ABSCESS 54 0.0175
438 MALNUTRITION 132 0.0175
439 FOLLICULITIS 59 0.0175
440 SKIN TIGHTNESS 62 0.0174
441 ANGIOPATHY 77 0.0174
442 ORAL CANDIDIASIS 152 0.0174
443 SYNOVITIS 162 0.0172
444 HYPERLIPIDAEMIA 165 0.0171
445 C-REACTIVE PROTEIN INCREASED 400 0.0171
446 PNEUMOTHORAX 185 0.0171
447 FEBRILE NEUTROPENIA 715 0.0170
448 CLOSTRIDIUM DIFFICILE INFECTION 234 0.0169
449 ABSCESS 182 0.0169
450 HEPATIC FAILURE 386 0.0168
451 PEMPHIGOID 75 0.0168
452 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 517 0.0167
453 VENOUS THROMBOSIS 51 0.0167
454 DRUG INTERACTION 1942 0.0167
455 ATELECTASIS 126 0.0167
456 OFF LABEL USE 7188 0.0165
457 PSORIATIC ARTHROPATHY 342 0.0165
458 OESOPHAGITIS 132 0.0165
459 MALABSORPTION 61 0.0164
460 ACUTE PULMONARY OEDEMA 71 0.0164
461 LIVER FUNCTION TEST ABNORMAL 406 0.0164
462 ADRENAL INSUFFICIENCY 105 0.0164
463 DRUG INTOLERANCE 983 0.0163
464 TYPE 1 DIABETES MELLITUS 64 0.0163
465 ILEUS 141 0.0162
466 PERICARDIAL EFFUSION 254 0.0162
467 PERICARDITIS 116 0.0161
468 CARDIOGENIC SHOCK 146 0.0160
469 GENERALISED OEDEMA 135 0.0159
470 INFECTION 1452 0.0158
471 DIALYSIS 176 0.0158
472 GASTROINTESTINAL INFECTION 92 0.0157
473 METASTASES TO LYMPH NODES 66 0.0157
474 METABOLIC ACIDOSIS 325 0.0154
475 LUNG NEOPLASM 55 0.0154
476 LEUKOCYTOSIS 198 0.0153
477 ABDOMINAL TENDERNESS 57 0.0151
478 HAEMATURIA 402 0.0151
479 RENAL FAILURE ACUTE 635 0.0149
480 HYPERKERATOSIS 58 0.0149
481 HAEMATOCRIT DECREASED 236 0.0149
482 DIABETES MELLITUS 860 0.0149
483 SKIN PLAQUE 78 0.0148
484 IMMUNODEFICIENCY 118 0.0148
485 THROMBOCYTOPENIA 1132 0.0148
486 AUTOIMMUNE DISORDER 66 0.0148
487 PARTIAL SEIZURES 52 0.0148
488 CATATONIA 51 0.0147
489 ORAL DISORDER 78 0.0147
490 DEVICE RELATED INFECTION 176 0.0146
491 COMA 511 0.0145
492 LEFT VENTRICULAR DYSFUNCTION 69 0.0145
493 HYPOMAGNESAEMIA 128 0.0145
494 JOINT EFFUSION 73 0.0143
495 HELICOBACTER INFECTION 55 0.0143
496 PULMONARY FIBROSIS 174 0.0142
497 PNEUMONITIS 237 0.0142
498 MALIGNANT MELANOMA 137 0.0141
499 METASTASES TO LUNG 105 0.0141
500 MYELOSUPPRESSION 59 0.0141
501 PLEURISY 67 0.0140
502 HEPATITIS ACUTE 66 0.0139
503 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 98 0.0139
504 METASTASIS 65 0.0139
505 HEPATOMEGALY 108 0.0139
506 PLEURAL EFFUSION 623 0.0139
507 DUODENAL ULCER 73 0.0138
508 HEPATOCELLULAR INJURY 169 0.0138
509 SKIN ULCER 255 0.0137
510 HYPOPHOSPHATAEMIA 65 0.0137
511 GENERALISED TONIC-CLONIC SEIZURE 140 0.0137
512 PULMONARY HYPERTENSION 218 0.0137
513 RESPIRATORY TRACT INFECTION 227 0.0136
514 PYREXIA 3327 0.0136
515 NYSTAGMUS 56 0.0135
516 GASTRIC ULCER 195 0.0134
517 NEPHROGENIC ANAEMIA 53 0.0133
518 PANCREATITIS ACUTE 208 0.0133
519 ANAEMIA 1838 0.0132
520 BLOOD PRESSURE SYSTOLIC INCREASED 164 0.0132
521 HEPATITIS 242 0.0132
522 COAGULOPATHY 169 0.0132
523 RENAL FAILURE 1402 0.0131
524 TRICUSPID VALVE INCOMPETENCE 75 0.0131
525 LYMPHADENOPATHY 325 0.0131
526 HYPERGLYCAEMIA 351 0.0131
527 HYPERCHOLESTEROLAEMIA 77 0.0130
528 GASTROINTESTINAL DISORDER 647 0.0130
529 HEPATIC FUNCTION ABNORMAL 309 0.0128
530 URINARY TRACT INFECTION 1446 0.0128
531 CELLULITIS 472 0.0127
532 PNEUMONIA 2781 0.0126
533 MITRAL VALVE INCOMPETENCE 109 0.0126
534 VIRAL INFECTION 279 0.0126
535 HEMIPARESIS 168 0.0126
536 IRON DEFICIENCY ANAEMIA 83 0.0125
537 MYELODYSPLASTIC SYNDROME 134 0.0125
538 ORAL HERPES 150 0.0124
539 HEPATIC CIRRHOSIS 155 0.0124
540 LOW BIRTH WEIGHT BABY 65 0.0123
541 ULCER 140 0.0123
542 FLUID OVERLOAD 181 0.0123
543 MENTAL STATUS CHANGES 259 0.0122
544 TACHYPNOEA 109 0.0122
545 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 82 0.0122
546 DYSPNOEA EXERTIONAL 292 0.0120
547 HAEMORRHAGE INTRACRANIAL 147 0.0120
548 NEUTROPENIC SEPSIS 63 0.0119
549 SHOCK 189 0.0119
550 FACIAL PARALYSIS 64 0.0118
551 PURPURA 80 0.0118
552 BLOOD ALKALINE PHOSPHATASE INCREASED 237 0.0118
553 EYELID PTOSIS 82 0.0118
554 GAMMA-GLUTAMYLTRANSFERASE INCREASED 209 0.0118
555 LUNG DISORDER 387 0.0117
556 OEDEMA 442 0.0117
557 SMALL INTESTINAL OBSTRUCTION 101 0.0116
558 LYMPHOMA 123 0.0113
559 HYPERTHERMIA 64 0.0113
560 BLOOD DISORDER 64 0.0112
561 HEPATIC ENCEPHALOPATHY 78 0.0111
562 MUSCLE ATROPHY 92 0.0111
563 BLOOD PRESSURE DIASTOLIC DECREASED 52 0.0110
564 CONCOMITANT DISEASE AGGRAVATED 50 0.0109
565 SUBARACHNOID HAEMORRHAGE 81 0.0109
566 FLANK PAIN 73 0.0109
567 ALANINE AMINOTRANSFERASE INCREASED 505 0.0109
568 OSTEOMYELITIS 153 0.0108
569 ATRIAL FLUTTER 66 0.0108
570 ECCHYMOSIS 58 0.0107
571 HAEMOGLOBIN DECREASED 800 0.0106
572 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 79 0.0106
573 CENTRAL NERVOUS SYSTEM LESION 120 0.0106
574 DRUG TOXICITY 144 0.0106
575 CONTRAINDICATED PRODUCT ADMINISTERED 171 0.0105
576 RENAL DISORDER 345 0.0105
577 INFLAMMATION 322 0.0105
578 SKIN CANCER 138 0.0105
579 JOINT RANGE OF MOTION DECREASED 79 0.0104
580 THERAPEUTIC RESPONSE DECREASED 422 0.0104
581 OPTIC NEURITIS 71 0.0103
582 GRAND MAL CONVULSION 95 0.0103
583 ARTERIOSCLEROSIS 73 0.0103
584 OSTEOPENIA 108 0.0102
585 RESPIRATORY RATE INCREASED 64 0.0102
586 ATAXIA 92 0.0101
587 SKIN HYPERPIGMENTATION 66 0.0101
588 VISUAL FIELD DEFECT 58 0.0101
589 PULMONARY OEDEMA 331 0.0101
590 RIGHT VENTRICULAR FAILURE 58 0.0101
591 INTESTINAL PERFORATION 81 0.0101
592 PROTHROMBIN TIME PROLONGED 53 0.0101
593 PHOTOSENSITIVITY REACTION 119 0.0100
594 POST PROCEDURAL COMPLICATION 146 0.0100
595 HAEMATOMA 203 0.0100
596 TOXICITY TO VARIOUS AGENTS 1119 0.0100
597 HEMIPLEGIA 64 0.0100
598 CONDITION AGGRAVATED 1734 0.0099
599 ALTERED STATE OF CONSCIOUSNESS 139 0.0099
600 POLYNEUROPATHY 73 0.0098
601 ELECTROLYTE IMBALANCE 76 0.0098
602 OSTEOPOROSIS 289 0.0098
603 OSTEONECROSIS 266 0.0098
604 INFUSION RELATED REACTION 365 0.0098
605 PREMATURE DELIVERY 106 0.0098
606 EXPOSURE DURING PREGNANCY 384 0.0097
607 ASPARTATE AMINOTRANSFERASE INCREASED 388 0.0096
608 UPPER RESPIRATORY TRACT INFECTION 305 0.0096
609 DRUG-INDUCED LIVER INJURY 151 0.0095
610 LOWER GASTROINTESTINAL HAEMORRHAGE 59 0.0095
611 PRODUCTIVE COUGH 281 0.0095
612 NODULE 83 0.0095
613 ABORTION SPONTANEOUS 290 0.0094
614 OXYGEN SATURATION DECREASED 319 0.0094
615 GOUT 118 0.0094
616 CARDIAC FAILURE 529 0.0094
617 CHOLECYSTITIS 81 0.0093
618 DIPLOPIA 169 0.0093
619 JAUNDICE 200 0.0092
620 NEOPLASM 68 0.0092
621 SINUSITIS 639 0.0092
622 MYOCLONUS 81 0.0091
623 HAEMOPTYSIS 191 0.0091
624 DISEASE PROGRESSION 641 0.0091
625 DIVERTICULITIS 174 0.0091
626 CARDIOMYOPATHY 100 0.0090
627 INFLAMMATORY BOWEL DISEASE 69 0.0090
628 RESPIRATORY DISORDER 190 0.0089
629 BLOOD POTASSIUM INCREASED 106 0.0089
630 ACUTE CORONARY SYNDROME 59 0.0089
631 SENSORY LOSS 53 0.0089
632 LIVER INJURY 105 0.0088
633 PULMONARY ARTERIAL HYPERTENSION 99 0.0088
634 CATARACT 336 0.0087
635 MASS 90 0.0087
636 NEUTROPHIL COUNT INCREASED 65 0.0086
637 ACNE 515 0.0086
638 GASTRITIS 166 0.0086
639 PERITONITIS BACTERIAL 69 0.0086
640 DIARRHOEA 3638 0.0086
641 CEREBRAL INFARCTION 158 0.0086
642 RENAL CYST 52 0.0086
643 CIRCULATORY COLLAPSE 116 0.0086
644 PETECHIAE 65 0.0085
645 RHEUMATOID ARTHRITIS 627 0.0085
646 LYMPHOCYTE COUNT DECREASED 103 0.0085
647 BLOOD PRESSURE FLUCTUATION 141 0.0085
648 SPINAL COMPRESSION FRACTURE 55 0.0084
649 RHABDOMYOLYSIS 255 0.0083
650 EJECTION FRACTION DECREASED 88 0.0083
651 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 264 0.0083
652 GASTROOESOPHAGEAL REFLUX DISEASE 464 0.0082
653 RED BLOOD CELL COUNT DECREASED 158 0.0082
654 CEREBRAL HAEMORRHAGE 220 0.0082
655 HYPERTENSION 1198 0.0082
656 EOSINOPHILIA 96 0.0081
657 BLOOD IRON DECREASED 57 0.0081
658 APHASIA 182 0.0081
659 PLATELET COUNT INCREASED 71 0.0080
660 THERAPEUTIC PRODUCT EFFECT DECREASED 159 0.0080
661 LOWER RESPIRATORY TRACT INFECTION 225 0.0080
662 TENDERNESS 61 0.0080
663 IMPAIRED HEALING 174 0.0080
664 EPILEPSY 159 0.0079
665 BLINDNESS 218 0.0079
666 HYPOCALCAEMIA 103 0.0078
667 HYPONATRAEMIA 321 0.0078
668 POST PROCEDURAL HAEMORRHAGE 70 0.0077
669 FISTULA 55 0.0077
670 NO THERAPEUTIC RESPONSE 93 0.0076
671 TREATMENT NONCOMPLIANCE 256 0.0076
672 HYPOKALAEMIA 240 0.0075
673 PREMATURE BABY 167 0.0075
674 ABDOMINAL PAIN 1228 0.0075
675 PLATELET COUNT DECREASED 540 0.0075
676 KIDNEY INFECTION 100 0.0075
677 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 179 0.0075
678 CARDIOMEGALY 77 0.0075
679 INTRAOCULAR PRESSURE INCREASED 73 0.0075
680 NERVOUS SYSTEM DISORDER 189 0.0074
681 CARDIAC ARREST 467 0.0074
682 ASPIRATION 55 0.0074
683 GENERAL PHYSICAL HEALTH DETERIORATION 518 0.0074
684 RENAL PAIN 54 0.0073
685 EMPHYSEMA 57 0.0073
686 RASH MACULO-PAPULAR 109 0.0072
687 PHARYNGITIS 66 0.0072
688 HEPATIC ENZYME INCREASED 312 0.0072
689 DIABETES MELLITUS INADEQUATE CONTROL 93 0.0072
690 JOINT STIFFNESS 131 0.0071
691 OBESITY 75 0.0071
692 SKIN DISORDER 149 0.0071
693 METASTASES TO LIVER 83 0.0071
694 MATERNAL EXPOSURE DURING PREGNANCY 336 0.0071
695 CHRONIC KIDNEY DISEASE 442 0.0071
696 MELAENA 117 0.0070
697 STOMATITIS 277 0.0070
698 TRANSFUSION 53 0.0070
699 GASTROENTERITIS VIRAL 82 0.0069
700 PARALYSIS 73 0.0069
701 TACHYCARDIA 433 0.0069
702 OEDEMA PERIPHERAL 670 0.0069
703 PANCREATITIS 270 0.0068
704 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 57 0.0068
705 ILL-DEFINED DISORDER 187 0.0067
706 WEIGHT DECREASED 1296 0.0067
707 DEHYDRATION 661 0.0067
708 ATRIAL FIBRILLATION 456 0.0066
709 BLOOD CREATINE PHOSPHOKINASE INCREASED 155 0.0066
710 ADVERSE REACTION 63 0.0066
711 PREGNANCY 113 0.0066
712 IMMUNE SYSTEM DISORDER 58 0.0066
713 SCAR 85 0.0066
714 WHITE BLOOD CELL COUNT DECREASED 476 0.0066
715 ABORTION INDUCED 50 0.0066
716 VENTRICULAR TACHYCARDIA 79 0.0065
717 HEPATIC STEATOSIS 86 0.0065
718 LIVER FUNCTION TEST INCREASED 78 0.0065
719 DEEP VEIN THROMBOSIS 347 0.0065
720 DYSURIA 175 0.0064
721 HYPOTHYROIDISM 131 0.0064
722 HYPOTENSION 908 0.0064
723 INTESTINAL OBSTRUCTION 157 0.0064
724 PAIN IN JAW 138 0.0064
725 QUALITY OF LIFE DECREASED 61 0.0063
726 COUGH 1148 0.0063
727 LIVER DISORDER 191 0.0063
728 BODY TEMPERATURE INCREASED 96 0.0063
729 JOINT SWELLING 484 0.0063
730 MUSCULAR WEAKNESS 513 0.0063
731 CYSTITIS 148 0.0062
732 SUBDURAL HAEMATOMA 70 0.0062
733 DELIRIUM 145 0.0062
734 VENTRICULAR FIBRILLATION 53 0.0062
735 SLEEP APNOEA SYNDROME 89 0.0061
736 VISUAL ACUITY REDUCED 178 0.0061
737 INFLUENZA 428 0.0061
738 GASTROINTESTINAL HAEMORRHAGE 420 0.0060
739 NIGHT SWEATS 128 0.0060
740 MUSCULOSKELETAL PAIN 273 0.0060
741 WHITE BLOOD CELL COUNT INCREASED 174 0.0060
742 SINUS TACHYCARDIA 63 0.0060
743 MYOCARDIAL ISCHAEMIA 57 0.0059
744 PHOTOPHOBIA 72 0.0059
745 GLAUCOMA 81 0.0058
746 PRODUCT USE ISSUE 689 0.0058
747 HYPOPHAGIA 101 0.0058
748 PULMONARY EMBOLISM 432 0.0058
749 METASTASES TO BONE 57 0.0058
750 PULMONARY CONGESTION 54 0.0057
751 CARDIO-RESPIRATORY ARREST 190 0.0057
752 COLON CANCER 59 0.0057
753 DYSPHAGIA 373 0.0057
754 DEPRESSED LEVEL OF CONSCIOUSNESS 160 0.0056
755 ACUTE MYOCARDIAL INFARCTION 131 0.0056
756 HAEMORRHOIDS 80 0.0055
757 ALOPECIA 793 0.0055
758 FOETAL EXPOSURE DURING PREGNANCY 305 0.0055
759 HALLUCINATION, VISUAL 75 0.0055
760 ARTHRITIS 292 0.0055
761 VOMITING 1794 0.0055
762 NEOPLASM MALIGNANT 238 0.0054
763 SEIZURE 376 0.0054
764 DYSARTHRIA 153 0.0054
765 URINARY RETENTION 127 0.0054
766 BLOOD TRIGLYCERIDES INCREASED 73 0.0053
767 MUSCULOSKELETAL STIFFNESS 311 0.0052
768 NEUTROPHIL COUNT DECREASED 129 0.0052
769 WOUND 80 0.0052
770 DERMATITIS 68 0.0052
771 NEURALGIA 83 0.0052
772 COLITIS ULCERATIVE 115 0.0052
773 CONVULSION 295 0.0052
774 DRUG INEFFECTIVE 4614 0.0051
775 DIABETIC KETOACIDOSIS 89 0.0051
776 CORONARY ARTERY DISEASE 136 0.0051
777 CONJUNCTIVITIS 54 0.0051
778 EYE PAIN 174 0.0051
779 ANOREXIA 65 0.0050
780 ABDOMINAL PAIN LOWER 95 0.0050
781 RENAL INJURY 134 0.0050
782 ISCHAEMIC STROKE 68 0.0050
783 CHILLS 413 0.0050
784 ARRHYTHMIA 179 0.0050
785 LOCALISED INFECTION 83 0.0050
786 SWELLING 303 0.0049
787 FLUID RETENTION 183 0.0049
788 UPPER GASTROINTESTINAL HAEMORRHAGE 64 0.0049
789 BRONCHITIS 270 0.0048
790 HAEMORRHAGE 347 0.0048
791 DEAFNESS 86 0.0048
792 CONFUSIONAL STATE 570 0.0048
793 HYPOKINESIA 51 0.0048
794 DECREASED APPETITE 726 0.0047
795 LUNG NEOPLASM MALIGNANT 140 0.0047
796 TREMOR 585 0.0047
797 DYSPNOEA 1880 0.0047
798 PLASMA CELL MYELOMA 118 0.0047
799 LETHARGY 201 0.0046
800 INTERVERTEBRAL DISC PROTRUSION 77 0.0046
801 RASH ERYTHEMATOUS 134 0.0046
802 ECZEMA 82 0.0046
803 BLISTER 169 0.0046
804 DISORIENTATION 143 0.0046
805 NEUROPATHY PERIPHERAL 274 0.0046
806 BLOOD SODIUM DECREASED 61 0.0046
807 HAEMATOCHEZIA 155 0.0045
808 HEART RATE INCREASED 312 0.0045
809 BLOOD PRESSURE DECREASED 212 0.0045
810 FOOT FRACTURE 62 0.0045
811 UNRESPONSIVE TO STIMULI 84 0.0045
812 BLOOD POTASSIUM DECREASED 97 0.0045
813 HERNIA 57 0.0045
814 THROMBOSIS 259 0.0044
815 ASTHENIA 1172 0.0044
816 CHOLELITHIASIS 109 0.0044
817 PSYCHOTIC DISORDER 97 0.0044
818 NECK PAIN 173 0.0044
819 TYPE 2 DIABETES MELLITUS 107 0.0044
820 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 69 0.0043
821 SOMNOLENCE 622 0.0043
822 ANAPHYLACTIC REACTION 148 0.0042
823 BLOOD PRESSURE INCREASED 449 0.0042
824 WEIGHT INCREASED 645 0.0042
825 BRADYCARDIA 162 0.0041
826 CHEST PAIN 569 0.0041
827 HEART RATE DECREASED 99 0.0041
828 NEPHROLITHIASIS 123 0.0041
829 MANIA 51 0.0041
830 RIB FRACTURE 59 0.0041
831 RASH PAPULAR 70 0.0040
832 BLOOD CHOLESTEROL INCREASED 130 0.0040
833 OSTEOARTHRITIS 116 0.0040
834 RASH 1135 0.0040
835 DRUG HYPERSENSITIVITY 571 0.0039
836 ABDOMINAL DISCOMFORT 431 0.0039
837 ABDOMINAL DISTENSION 281 0.0039
838 URINARY INCONTINENCE 85 0.0039
839 FRACTURE 54 0.0039
840 MYALGIA 479 0.0039
841 SPEECH DISORDER 150 0.0039
842 ARTHRALGIA 1018 0.0038
843 RHINORRHOEA 157 0.0038
844 EAR INFECTION 62 0.0038
845 POOR QUALITY SLEEP 54 0.0038
846 NO ADVERSE EVENT 357 0.0038
847 VISUAL IMPAIRMENT 301 0.0038
848 NAUSEA 2096 0.0038
849 PALLOR 69 0.0038
850 DRY EYE 93 0.0037
851 AMNESIA 186 0.0037
852 GASTRIC DISORDER 111 0.0037
853 COGNITIVE DISORDER 118 0.0037
854 RECTAL HAEMORRHAGE 117 0.0036
855 HEADACHE 1611 0.0036
856 MALAISE 1174 0.0036
857 OROPHARYNGEAL PAIN 222 0.0036
858 IMPAIRED WORK ABILITY 60 0.0036
859 HAEMATEMESIS 69 0.0036
860 ANGIOEDEMA 111 0.0036
861 ANGINA PECTORIS 81 0.0036
862 HYPOGLYCAEMIA 130 0.0035
863 CARDIOVASCULAR DISORDER 77 0.0035
864 DEATH 2009 0.0035
865 EYE DISORDER 77 0.0035
866 CONTUSION 229 0.0034
867 BONE DENSITY DECREASED 83 0.0034
868 MENTAL DISORDER 104 0.0034
869 DRUG EXPOSURE DURING PREGNANCY 116 0.0034
870 EPISTAXIS 187 0.0034
871 DRUG EFFECT INCOMPLETE 124 0.0034
872 INTERNATIONAL NORMALISED RATIO INCREASED 88 0.0034
873 FATIGUE 1752 0.0034
874 SURGERY 115 0.0034
875 FIBROMYALGIA 51 0.0033
876 DISCOMFORT 113 0.0033
877 NASOPHARYNGITIS 390 0.0033
878 PERIPHERAL SWELLING 309 0.0032
879 HALLUCINATION 162 0.0032
880 ORAL PAIN 52 0.0032
881 LIMB INJURY 54 0.0031
882 MOBILITY DECREASED 150 0.0031
883 ARTHROPATHY 115 0.0031
884 ABDOMINAL PAIN UPPER 441 0.0031
885 WHEEZING 114 0.0031
886 SKIN DISCOLOURATION 101 0.0031
887 LOSS OF CONSCIOUSNESS 290 0.0031
888 CEREBROVASCULAR ACCIDENT 403 0.0030
889 MOOD ALTERED 60 0.0030
890 PAIN 1202 0.0030
891 CHROMATURIA 51 0.0030
892 DYSPHONIA 117 0.0029
893 ERYTHEMA 431 0.0029
894 CARDIAC FAILURE CONGESTIVE 205 0.0029
895 HIP FRACTURE 65 0.0029
896 NASAL CONGESTION 105 0.0029
897 BACK PAIN 476 0.0029
898 VERTIGO 129 0.0029
899 DYSSTASIA 60 0.0028
900 CHEST DISCOMFORT 198 0.0028
901 PAIN IN EXTREMITY 614 0.0028
902 DYSPEPSIA 193 0.0028
903 AGITATION 163 0.0028
904 RESPIRATORY ARREST 65 0.0028
905 HYPOAESTHESIA 296 0.0027
906 MEDICATION ERROR 111 0.0027
907 DYSKINESIA 81 0.0027
908 OVERDOSE 384 0.0027
909 POLLAKIURIA 79 0.0027
910 PARAESTHESIA 300 0.0026
911 PRURITUS 590 0.0026
912 ACCIDENTAL OVERDOSE 64 0.0026
913 DISTURBANCE IN ATTENTION 104 0.0026
914 LABORATORY TEST ABNORMAL 52 0.0026
915 GAIT DISTURBANCE 356 0.0026
916 MYOCARDIAL INFARCTION 380 0.0026
917 ABASIA 63 0.0025
918 SKIN EXFOLIATION 139 0.0025
919 HYPERSENSITIVITY 327 0.0025
920 SYNCOPE 186 0.0025
921 SWELLING FACE 118 0.0025
922 BLOOD GLUCOSE INCREASED 357 0.0025
923 VISION BLURRED 234 0.0025
924 CARDIAC DISORDER 170 0.0024
925 TINNITUS 80 0.0024
926 PALPITATIONS 202 0.0024
927 THERAPY CESSATION 79 0.0024
928 TRANSIENT ISCHAEMIC ATTACK 63 0.0024
929 FALL 560 0.0024
930 DEPRESSED MOOD 85 0.0023
931 SLEEP DISORDER 103 0.0023
932 RESTLESSNESS 63 0.0023
933 MALIGNANT NEOPLASM PROGRESSION 147 0.0023
934 BONE PAIN 98 0.0023
935 ELECTROCARDIOGRAM QT PROLONGED 57 0.0023
936 INSOMNIA 443 0.0022
937 DEPRESSION 391 0.0022
938 BURNING SENSATION 112 0.0022
939 ABNORMAL BEHAVIOUR 71 0.0021
940 RASH PRURITIC 76 0.0021
941 INJURY 121 0.0021
942 INFLUENZA LIKE ILLNESS 135 0.0021
943 MIGRAINE 127 0.0020
944 DIZZINESS 714 0.0020
945 THROAT IRRITATION 60 0.0020
946 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 77 0.0020
947 ROAD TRAFFIC ACCIDENT 60 0.0020
948 MEMORY IMPAIRMENT 192 0.0020
949 BALANCE DISORDER 126 0.0020
950 PANIC ATTACK 53 0.0020
951 CONSTIPATION 275 0.0020
952 HOSPITALISATION 170 0.0019
953 UNEVALUABLE EVENT 110 0.0019
954 FEELING HOT 83 0.0019
955 STRESS 91 0.0019
956 MUSCLE SPASMS 242 0.0018
957 DRY MOUTH 98 0.0017
958 URTICARIA 194 0.0017
959 ANXIETY 360 0.0017
960 PROSTATE CANCER 87 0.0017
961 ADVERSE DRUG REACTION 87 0.0017
962 FLUSHING 134 0.0017
963 ADVERSE EVENT 110 0.0017
964 SUICIDE ATTEMPT 72 0.0016
965 DRUG EFFECT DECREASED 88 0.0016
966 ASTHMA 107 0.0016
967 FLATULENCE 64 0.0016
968 EMOTIONAL DISTRESS 105 0.0016
969 HOT FLUSH 74 0.0016
970 INTENTIONAL PRODUCT MISUSE 90 0.0015
971 MULTIPLE SCLEROSIS 52 0.0015
972 UNDERDOSE 77 0.0015
973 HYPERHIDROSIS 140 0.0015
974 BLADDER CANCER 59 0.0014
975 INTENTIONAL OVERDOSE 61 0.0014
976 PRODUCT SUBSTITUTION ISSUE 60 0.0014
977 BLOOD GLUCOSE DECREASED 51 0.0014
978 DRUG DOSE OMISSION 225 0.0014
979 IRRITABILITY 61 0.0013
980 BREAST CANCER 92 0.0013
981 FEELING ABNORMAL 224 0.0012
982 INCORRECT DOSE ADMINISTERED 138 0.0012
983 SUICIDAL IDEATION 80 0.0012
984 DYSGEUSIA 61 0.0011
985 DRY SKIN 95 0.0011
986 PRODUCT DOSE OMISSION 74 0.0011
987 PRODUCT DOSE OMISSION ISSUE 63 0.0011
988 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 64 0.0009
989 PSORIASIS 77 0.0009
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 53 0.0008
991 DRUG DEPENDENCE 70 0.0007
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 72 0.0006
993 PRODUCT QUALITY ISSUE 69 0.0006
994 INJECTION SITE PAIN 91 0.0005